A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Recruiting · NCT07392736 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-02-06 | NCT07392736 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Advenchen Laboratories, LLC | 4 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital of Shantou University Medical College | Shantou | China | 4 |
| Fujian Cancer Hospital | Fuzhou | China | 3 |
| Guangxi Medical University Cancer Hospital | Nanning | China | 24 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Hunan Cancer Hospital | Hunan | China | 1 |
| Liuzhou Workers' Hospital | Liuzhou | China | 2 |
| National GCP Center for Anticancer Drugs,The Independent Ethics Committee | Beijing | China | 1 |
| Sir Run Run Shaw Hospital Zhejiang University School of Medicine | Hangzhou | China | 10 |
| The Cancer Hospital of the Chinese Academy of Medical Sciences | Beijing | China | 2 |
| The First Affiliated Hospital of Guilin Medical Universty | Guilin | China | 1 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi’an | China | 2 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| The People's Hospital of Guangxi Zhuang Autonomous Region | Nanning | China | 3 |
| Yuebei People's Hospital | Shaoguan | China | 1 |
| Zhejiang Cancer Hospital | Hangzhou | China | 21 |